Copyright Reports & Markets. All rights reserved.

Global and United States Gene Therapy for Mucopolysaccharidosis Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Gene Therapy for Mucopolysaccharidosis Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Intravenous
    • 1.2.3 ICV
    • 1.2.4 Intracerebral
    • 1.2.5 Intracisternal
  • 1.3 Market by Application
    • 1.3.1 Global Gene Therapy for Mucopolysaccharidosis Market Share by Application: 2020 VS 2026
    • 1.3.2 Mucopolysaccharidosis I
    • 1.3.3 Mucopolysaccharidosis II
    • 1.3.4 Mucopolysaccharidosis III A
    • 1.3.5 Mucopolysaccharidosis III B
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Gene Therapy for Mucopolysaccharidosis Market Perspective (2015-2026)
  • 2.2 Global Gene Therapy for Mucopolysaccharidosis Growth Trends by Regions
    • 2.2.1 Gene Therapy for Mucopolysaccharidosis Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Gene Therapy for Mucopolysaccharidosis Historic Market Share by Regions (2015-2020)
    • 2.2.3 Gene Therapy for Mucopolysaccharidosis Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Gene Therapy for Mucopolysaccharidosis Players by Market Size
    • 3.1.1 Global Top Gene Therapy for Mucopolysaccharidosis Players by Revenue (2015-2020)
    • 3.1.2 Global Gene Therapy for Mucopolysaccharidosis Revenue Market Share by Players (2015-2020)
  • 3.2 Global Gene Therapy for Mucopolysaccharidosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Gene Therapy for Mucopolysaccharidosis Revenue
  • 3.4 Global Gene Therapy for Mucopolysaccharidosis Market Concentration Ratio
    • 3.4.1 Global Gene Therapy for Mucopolysaccharidosis Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy for Mucopolysaccharidosis Revenue in 2019
  • 3.5 Key Players Gene Therapy for Mucopolysaccharidosis Area Served
  • 3.6 Key Players Gene Therapy for Mucopolysaccharidosis Product Solution and Service
  • 3.7 Date of Enter into Gene Therapy for Mucopolysaccharidosis Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Therapy for Mucopolysaccharidosis Breakdown Data by Type (2015-2026)

  • 4.1 Global Gene Therapy for Mucopolysaccharidosis Historic Market Size by Type (2015-2020)
  • 4.2 Global Gene Therapy for Mucopolysaccharidosis Forecasted Market Size by Type (2021-2026)

5 Gene Therapy for Mucopolysaccharidosis Breakdown Data by Application (2015-2026)

  • 5.1 Global Gene Therapy for Mucopolysaccharidosis Historic Market Size by Application (2015-2020)
  • 5.2 Global Gene Therapy for Mucopolysaccharidosis Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Gene Therapy for Mucopolysaccharidosis Market Size (2015-2026)
  • 6.2 North America Gene Therapy for Mucopolysaccharidosis Market Size by Type (2015-2020)
  • 6.3 North America Gene Therapy for Mucopolysaccharidosis Market Size by Application (2015-2020)
  • 6.4 North America Gene Therapy for Mucopolysaccharidosis Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Gene Therapy for Mucopolysaccharidosis Market Size (2015-2026)
  • 7.2 Europe Gene Therapy for Mucopolysaccharidosis Market Size by Type (2015-2020)
  • 7.3 Europe Gene Therapy for Mucopolysaccharidosis Market Size by Application (2015-2020)
  • 7.4 Europe Gene Therapy for Mucopolysaccharidosis Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Gene Therapy for Mucopolysaccharidosis Market Size (2015-2026)
  • 8.2 China Gene Therapy for Mucopolysaccharidosis Market Size by Type (2015-2020)
  • 8.3 China Gene Therapy for Mucopolysaccharidosis Market Size by Application (2015-2020)
  • 8.4 China Gene Therapy for Mucopolysaccharidosis Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Gene Therapy for Mucopolysaccharidosis Market Size (2015-2026)
  • 9.2 Japan Gene Therapy for Mucopolysaccharidosis Market Size by Type (2015-2020)
  • 9.3 Japan Gene Therapy for Mucopolysaccharidosis Market Size by Application (2015-2020)
  • 9.4 Japan Gene Therapy for Mucopolysaccharidosis Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Gene Therapy for Mucopolysaccharidosis Market Size (2015-2026)
  • 10.2 Southeast Asia Gene Therapy for Mucopolysaccharidosis Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Gene Therapy for Mucopolysaccharidosis Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Gene Therapy for Mucopolysaccharidosis Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 Sangamo Therapeutics
    • 11.1.1 Sangamo Therapeutics Company Details
    • 11.1.2 Sangamo Therapeutics Business Overview
    • 11.1.3 Sangamo Therapeutics Gene Therapy for Mucopolysaccharidosis Introduction
    • 11.1.4 Sangamo Therapeutics Revenue in Gene Therapy for Mucopolysaccharidosis Business (2015-2020))
    • 11.1.5 Sangamo Therapeutics Recent Development
  • 11.2 Swedish Orphan Biovitrum
    • 11.2.1 Swedish Orphan Biovitrum Company Details
    • 11.2.2 Swedish Orphan Biovitrum Business Overview
    • 11.2.3 Swedish Orphan Biovitrum Gene Therapy for Mucopolysaccharidosis Introduction
    • 11.2.4 Swedish Orphan Biovitrum Revenue in Gene Therapy for Mucopolysaccharidosis Business (2015-2020)
    • 11.2.5 Swedish Orphan Biovitrum Recent Development
  • 11.3 uniQure
    • 11.3.1 uniQure Company Details
    • 11.3.2 uniQure Business Overview
    • 11.3.3 uniQure Gene Therapy for Mucopolysaccharidosis Introduction
    • 11.3.4 uniQure Revenue in Gene Therapy for Mucopolysaccharidosis Business (2015-2020)
    • 11.3.5 uniQure Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Gene Therapy for Mucopolysaccharidosis Scope and Market Size
    Gene Therapy for Mucopolysaccharidosis market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gene Therapy for Mucopolysaccharidosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Intravenous
    ICV
    Intracerebral
    Intracisternal

    Market segment by Application, split into
    Mucopolysaccharidosis I
    Mucopolysaccharidosis II
    Mucopolysaccharidosis III A
    Mucopolysaccharidosis III B

    Based on regional and country-level analysis, the Gene Therapy for Mucopolysaccharidosis market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Gene Therapy for Mucopolysaccharidosis market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Sangamo Therapeutics
    Swedish Orphan Biovitrum
    uniQure
    ...

    Buy now